Skip to content

Myocardial Ischaemia After Exposure to Diesel Exhaust

Myocardial Ischaemia After Exposure to Diesel Exhaust

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01661582
Acronym
MIDAS
Enrollment
28
Registered
2012-08-09
Start date
2012-09-20
Completion date
2015-02-13
Last updated
2024-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Keywords

Air Pollution, Myocardial Ischaemia, Coronary Blood Flow, Diesel Exhaust, Troponin, Electrocardiography

Brief summary

Exposure to particulate air pollution is associated with increases in cardiovascular mortality and morbidity. The pathophysiological mechanisms underlying this observation are emerging, and exposure to particulate air pollution has been shown to result in increases in blood pressure and arterial tone, impaired vascular function and an increased tendency for blood to clot as well as an increase in atherosclerotic plaque burden. Recent evidence from panel studies and controlled exposure studies have suggested an increase in myocardial ischaemia (a reduction in blood flow to the heart) following exposure. In this study we aim to investigate directly myocardial (heart) blood flow following exposure to diesel exhaust (as a model of urban air pollution) using CT/PET myocardial perfusion imaging in male patients with stable coronary disease and healthy male controls. We hypothesize that following exposure to dilute diesel exhaust: 1. Myocardial blood flow will be reduced 2. Coronary flow reserve will be impaired 3. The magnitude of impairment will be higher in patients with coronary disease as compared to healthy controls

Interventions

OTHERCT/PET Myocardial Perfusion Imaging using O-15 water
OTHERCoronary blood flow measured by doppler echocardiography

Sponsors

National Institute for Public Health and the Environment (RIVM)
CollaboratorOTHER_GOV
British Heart Foundation
CollaboratorOTHER
University of Edinburgh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers will be taking no regular medication, have a normal electrocardiogram and exercise stress test * Patients with a previous history of myocardial infarction or successful coronary revascularization (PTCA or coronary artery bypass grafting) but without symptoms of angina pectoris will be recruited

Exclusion criteria

* Healthy volunteers: * Regular medication * Abnormal 12-lead electrocardiogram * Abnormal exercise stress test * Patients with coronary disease * Acute coronary syndrome within past 3 months * Impaired left ventricular function * Significant valvular heart disease * Left ventricular hypertrophy * Resting conduction defect * Digoxin use * Renal impairment (eGFR \<60 mL/min) * Hepatic impairment * Asthma

Design outcomes

Primary

MeasureTime frameDescription
Myocardial blood flow and coronary flow reserve measured by CT/PET O-15 imagingImmediately following exposureMyocardial blood flow will be measured at rest and at peak adenosine stress using CT/PET O-15 myocardial perfusion imaging immediately following exposure to diesel exhaust and filtered air

Secondary

MeasureTime frameDescription
Coronary flow reserve determined using doppler echocardiography1 hour following exposureCoronary blood flow will be determined in the left anterior descending coronary artery using doppler echocardiography at rest and at peak adenosine stress 1 hour following exposure to diesel exhaust and filtered air
Ultra-sensitive cardiac troponin-IBefore, 2 and 24 hours following exposureBlood samples will be obtained for measurement of cardiac troponin-I
ST segment deviation on continuous 12-lead electrocardiographyDuring and for the 24 hours aftet exposureA 12-lead electrocardiogram will be continuously recorded using Holter ECG monitor

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026